Pepgen inc. (pepg) investigation: bronstein, gewirtz & grossman, llc encourages investors to seek compensation for alleged wrongdoings

New york--(business wire)---- $pepg #classaction--attorney advertising--bronstein, gewirtz & grossman, llc is investigating potential claims on behalf of purchasers of pepgen inc. (“pepgen” or “the company”) (nasdaq: pepg). investors who purchased pepgen securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/pepg. investigation details pepgen released data from its ongoing phase 2 trial of its drug candidate pgn-edo51 on july 30, 2024. follo.
PEPG Ratings Summary
PEPG Quant Ranking